tradingkey.logo

IDEXX Laboratories Inc

IDXX
699.680USD
-4.520-0.64%
Market hours ETQuotes delayed by 15 min
55.97BMarket Cap
55.07P/E TTM

IDEXX Laboratories Inc

699.680
-4.520-0.64%
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison

TradingKey Stock Score of IDEXX Laboratories Inc

Currency: USD Updated: 2025-12-12

Key Insights

IDEXX Laboratories Inc's fundamentals are relatively healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 37/208 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 768.16.In the medium term, the stock price is expected to remain stable.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

IDEXX Laboratories Inc's Score

Industry at a Glance

Industry Ranking
37 / 208
Overall Ranking
112 / 4592
Industry
Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Analyst Rating

Based on 16 analysts
Buy
Current Rating
768.158
Target Price
+8.70%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

IDEXX Laboratories Inc Highlights

StrengthsRisks
IDEXX Laboratories, Inc. develops, manufactures and distributes products and provides services primarily for the companion animal veterinary, livestock and poultry, dairy and water testing industries. The Company also provides human medical point-of-care and laboratory diagnostics. Its segments include Companion Animal Group (CAG), Water quality products (Water), and Livestock, Poultry and Dairy (LPD). The CAG segment offers diagnostic and information management-based products and services for the companion animal veterinary industry, including in-clinic diagnostic solutions, outside reference laboratory services, and veterinary software and services. The Water segment provides testing solutions for accurate detection and quantification of various microbiological parameters in water. The LPD segment provides diagnostic tests, services, and related instrumentation that are used to manage the health status of livestock and poultry, and to improve the quality and safety of milk.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 15.74% year-on-year.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 3.90B.
Overvalued
The company’s latest PE is 55.42, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 77.76M shares, decreasing 4.93% quarter-over-quarter.
Held by ETHSX
Star Investor ETHSX holds 21.60K shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 0.21.

Financial Health

Currency: USD Updated: 2025-12-12

The current financial score of IDEXX Laboratories Inc is 8.85, ranking 26/208 in the Healthcare Equipment & Supplies industry. Its financial status is stable, and its operating efficiency is high. Its latest quarterly revenue reached 1.11B, representing a year-over-year increase of 13.29%, while its net profit experienced a year-over-year increase of 17.94%.

Score

Industry at a Glance

Previous score
8.85
Change
0

Financials

7.58

Key Metrics

Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.

Quality of Earnings

8.80

Operational Efficiency

10.00

Growth Potential

10.00

Shareholder Returns

7.88

IDEXX Laboratories Inc's Company Valuation

Currency: USD Updated: 2025-12-12

The current valuation score of IDEXX Laboratories Inc is 4.64, ranking 195/208 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is 55.42, which is 14.34% below the recent high of 63.37 and 40.32% above the recent low of 33.08.

Score

Industry at a Glance

Previous score
4.64
Change
0

Valuation Dimensions

P/E
P/B
P/S
P/CF
Industry Ranking 37/208
Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2025-12-12

The current earnings forecast score of IDEXX Laboratories Inc is 8.00, ranking 59/208 in the Healthcare Equipment & Supplies industry. The average price target for IDEXX Laboratories Inc is 787.50, with a high of 850.00 and a low of 475.21.

Score

Industry at a Glance

Previous score
8.00
Change
0

Support & Resistance

Relevant data have not been disclosed by the company yet.

Analyst Rating

Based on 16 analysts
Buy
Current Rating
768.158
Target Price
+8.70%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

112
Total
6
Median
9
Average
Company name
Ratings
Analysts
IDEXX Laboratories Inc
IDXX
16
Medtronic PLC
MDT
35
Stryker Corp
SYK
32
Abbott Laboratories
ABT
31
Dexcom Inc
DXCM
31
Zimmer Biomet Holdings Inc
ZBH
30
1
2
3
...
23

Financial Forecasting

EPS
Revenue
Net Profit
EBIT
Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-12-12

The current price momentum score of IDEXX Laboratories Inc is 7.25, ranking 95/208 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 761.04 and the support level at 656.31, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score
7.30
Change
-0.05

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators
Sell(1)
Neutral(4)
Buy(1)
Indicators
Value
Direction
MACD(12,26,9)
-11.661
Neutral
RSI(14)
49.324
Neutral
STOCH(KDJ)(9,3,3)
20.583
Neutral
ATR(14)
17.963
Low Volatility
CCI(14)
-81.549
Neutral
Williams %R
86.258
Oversold
TRIX(12,20)
0.180
Sell
StochRSI(14)
59.534
Buy
Moving Average
Sell(3)
Neutral(0)
Buy(3)
Indicators
Value
Direction
MA5
703.848
Sell
MA10
713.844
Sell
MA20
715.380
Sell
MA50
680.732
Buy
MA100
655.996
Buy
MA200
565.587
Buy

Institutional Confidence

Currency: USD Updated: 2025-12-12

The current institutional shareholding score of IDEXX Laboratories Inc is 10.00, ranking 1/208 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 97.19%, representing a quarter-over-quarter decrease of 2.54%. The largest institutional shareholder is The Vanguard, holding a total of 9.93M shares, representing 12.43% of shares outstanding, with 2.57% increase in holdings.

Score

Industry at a Glance

Previous score
10.00
Change
0

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name
Shares Held
Chg %
The Vanguard Group, Inc.
Star Investors
9.84M
+0.20%
BlackRock Institutional Trust Company, N.A.
5.30M
-2.44%
State Street Investment Management (US)
3.55M
-2.62%
Fundsmith LLP
2.64M
-0.34%
Geode Capital Management, L.L.C.
2.46M
+2.26%
Baron Capital Management, Inc.
Star Investors
2.03M
-1.32%
Invesco Capital Management (QQQ Trust)
1.65M
-0.35%
Principal Global Investors (Equity)
1.13M
+0.16%
Polen Capital Management, LLC
1.20M
+1519.07%
Walter Scott & Partners Ltd.
756.69K
+374.18%
1
2

Risk Assessment

Currency: USD Updated: 2025-12-12

The current risk assessment score of IDEXX Laboratories Inc is 8.55, ranking 21/208 in the Healthcare Equipment & Supplies industry. The company's beta value is 1.66. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.

Score

Industry at a Glance

Previous score
8.55
Change
0
Beta vs S&P 500 index
1.67
VaR
+3.49%
240-Day Maximum Drawdown
+23.03%
240-Day Volatility
+40.33%

Return

Best Daily Return
60 days
+14.84%
120 days
+27.49%
5 years
+27.49%
Worst Daily Return
60 days
-3.27%
120 days
-6.60%
5 years
-9.79%
Sharpe Ratio
60 days
+1.16
120 days
+1.41
5 years
+0.39

Risk Assessment

Maximum Drawdown
240 days
+23.03%
3 years
+37.41%
5 years
+54.00%
Return-to-Drawdown Ratio
240 days
+3.03
3 years
+0.41
5 years
+0.15
Skewness
240 days
+4.64
3 years
+3.35
5 years
+1.97

Volatility

Realised Volatility
240 days
+40.33%
5 years
+34.57%
Standardised True Range
240 days
+2.14%
5 years
+2.03%
Downside Risk-Adjusted Return
120 days
+366.78%
240 days
+366.78%
Maximum Daily Upside Volatility
60 days
+38.02%
Maximum Daily Downside Volatility
60 days
+29.65%

Liquidity

Average Turnover Rate
60 days
+0.71%
120 days
+0.87%
5 years
--
Turnover Deviation
20 days
+21.05%
60 days
-0.39%
120 days
+23.01%

Peer Comparison

Healthcare Equipment & Supplies
IDEXX Laboratories Inc
IDEXX Laboratories Inc
IDXX
7.81 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Lantheus Holdings Inc
Lantheus Holdings Inc
LNTH
8.62 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
LivaNova PLC
LivaNova PLC
LIVN
8.61 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Becton Dickinson and Co
Becton Dickinson and Co
BDX
8.46 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Tactile Systems Technology Inc
Tactile Systems Technology Inc
TCMD
8.43 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Align Technology Inc
Align Technology Inc
ALGN
8.39 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more

FAQs

How does TradingKey generate the Stock Score of IDEXX Laboratories Inc?

The TradingKey Stock Score provides a comprehensive assessment of IDEXX Laboratories Inc based on 34 indicators derived from over 100 underlying data points.
These indicators are categorised into six key dimensions: financial health, company profile, earnings forecasts, price momentum, institutional confidence, and risk assessment, collectively providing investors with a thorough analysis of IDEXX Laboratories Inc’s performance and outlook.

How do we generate the financial health score of IDEXX Laboratories Inc?

To generate the financial health score of IDEXX Laboratories Inc, we analyse various key financial indicators across several core dimensions, including financial fundamentals, earnings quality, operational efficiency, growth potential, and shareholder returns.
By integrating these comprehensive data, the financial health score not only reflects IDEXX Laboratories Inc's overall stability, operational efficiency, and growth potential but also captures the investment returns delivered to shareholders. This score aims to support rational decision-making for investors and other stakeholders. A higher score indicates a better financial health of IDEXX Laboratories Inc.

How do we generate the company valuation score of IDEXX Laboratories Inc?

To generate the company valuation score of IDEXX Laboratories Inc, we use several key financial ratios, including P/E, P/B, P/S, and P/CF. These metrics compare IDEXX Laboratories Inc’s market value to its earnings, assets, sales, and cash flow, serving as core indicators for assessing company value.
By analysing these ratios in an all-round manner, the valuation score reflects not only the market’s current perception of IDEXX Laboratories Inc’s value but also its future profitability and growth potential, thereby supporting more informed investment decisions. A higher score indicates a fairer valuation of IDEXX Laboratories Inc.

How do we generate the earnings forecast score of IDEXX Laboratories Inc?

To calculate the earnings forecast score of IDEXX Laboratories Inc, we consider various key indicators such as analyst ratings, financial forecasts, support and resistance levels, and peer comparisons:
Current ratings and price targets directly reflect analysts’ expectations, while the upside space indicates their views on the stock’s growth potential.
Financial metrics like earnings per share (EPS), revenue, net income, and earnings before interest and taxes (EBIT) are core measures for assessing profitability.
By analysing the high, median, and low ranges of the target price, we can identify price trends and determine key support and resistance levels.
Comparing these indicators against peers provides context for the stock’s performance and helps anchor more realistic expectations.
These factors together form a comprehensive earnings forecast score that accurately reflects the stock’s expected financial performance and growth potential. A higher score suggests that analysts have a more optimistic outlook on IDEXX Laboratories Inc’s future.

How do we generate the price momentum score of IDEXX Laboratories Inc?

When generating the price momentum score for IDEXX Laboratories Inc, we examine momentum indicators including support and resistance levels as well as volume metrics.
Support levels represent price points where buying interest is strong enough to prevent further declines, while resistance levels indicate prices where selling pressure may hinder upward movement. By analysing typical price volume alongside total volume, we assess overall market activity and liquidity. These indicators help identify price trends and potential shifts, enabling more accurate predictions of future earnings.
This comprehensive approach can reflect market sentiment and enable rational forecasts of IDEXX Laboratories Inc’s prices. A higher score indicates a more stable short-term price trend for IDEXX Laboratories Inc.

How do we generate the institutional confidence score of IDEXX Laboratories Inc?

To generate the institutional confidence score of IDEXX Laboratories Inc, we analyse both the proportion of shares held by institutions and the number of shares they own. A higher institutional ownership percentage indicates strong confidence of professional investors, which is generally a positive signal about IDEXX Laboratories Inc’s potential. By examining the number of shares held, we gain deeper insight into institutions’ commitment and attitude toward the stock, as institutional investors typically conduct thorough analysis before making investment decisions. Understanding institutional confidence helps us refine earnings forecasts and provides a more reliable perspective on the company’s future performance and market stability. A higher score indicates greater institutional endorsement of IDEXX Laboratories Inc.

How do we generate the risk management score of IDEXX Laboratories Inc?

To assess the risk management score of IDEXX Laboratories Inc, we examine multiple key indicators related to returns, risk, volatility, and liquidity.
The highest and lowest daily returns reflect the potential size of gains and losses, while the Sharpe ratio measures risk-adjusted return performance. On the risk side, we analyse maximum drawdown and the return-to-drawdown ratio to identify extreme loss scenarios. Skewness helps assess the distribution of returns and whether performance may be biased. Volatility indicators—such as realised volatility and standardised true range—reveal price fluctuations. Downside risk-adjusted returns provide insight into potential losses and gains. Lastly, liquidity metrics like average turnover rate and turnover deviation indicate how actively the stock is traded.
These indicators together provide a multi-dimensional understanding of IDEXX Laboratories Inc’s risk-return profile, serving as core factors of the risk management score. A higher score indicates lower risk on the side of IDEXX Laboratories Inc.
KeyAI